Market Place
Sourcing Support
Tiefenbacher API+ Ingredients Offers Custom Synthesis Of Intermediates & Apis
08 May 2024 //
PRESS RELEASE
Tiefenbacher Group Renovation Of Headquarters In Hamburg
02 May 2024 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.
09 Apr 2024 //
PRESS RELEASE
Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate
08 Apr 2024 //
PRESS RELEASE
Tiefenbacher Group awarded the EcoVadis Silver Medal!
19 Mar 2024 //
PRESS RELEASE
Tiefenbacher Group on awareness for rare disease day
29 Feb 2024 //
PRESS RELEASE
Tiefenbacher Group Renovation of our Headquarters
14 Feb 2024 //
PRESS RELEASE
Aet Laboratories 20Th Anniversary Celebration
03 Jan 2024 //
PRESS RELEASE
Tiefenbacher Launch anticoagulant Rivaroxaban in Canada
16 Nov 2023 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals Launch Of Generic Teriflunomide
27 Sep 2023 //
PRESS RELEASE
Successful Approval of manufacturing and laboratory facilities by Saudi Food and Drug Authority
10 May 2023 //
PRESS RELEASE
Tiefenbacher Pharma Successfully Launches The Antihistamine Bilastine
14 Mar 2023 //
PRESS RELEASE
Tiefenbacher Manufacturing Sites Have Been Successfully Registered By The UAE
25 Feb 2023 //
PRESS RELEASE
Tiefenbacher Successfully Launches Generic Version Of The Psoriasis Apremilast
01 Dec 2022 //
PRESS RELEASE
Meet Tiefenbacher Group At Bepharma In Mexico City From October 10-12!
15 Sep 2022 //
PRESS RELEASE
Alfred E. Tiefenbacher`s Pirfenidone Receives Approval in the EMA
28 Jun 2022 //
FDA
Alfred E. Tiefenbacher` Pirfenidone AET Receives Approval in Europe
28 Jun 2022 //
EMA
Tiefenbacher Group Becomes Member Of (Psci)
24 May 2022 //
PRESS RELEASE
Tiefenbacher Group Opens New Site For Highly Potent Drugs In India
05 May 2022 //
PRESS RELEASE
Four Drugs Recommended For Approval By Chmp At April Meeting
25 Apr 2022 //
MEDWATCH
World Health Day @ Tiefenbacher Group
07 Apr 2022 //
PRESS RELEASE
Tiefenbacher Group At Dcat 2022 – Thanks For Meeting Us In New York City!
29 Mar 2022 //
PRESS RELEASE
Tiefenbacher Group Stands With Ukraine
08 Mar 2022 //
PRESS RELEASE
Tiefenbacher Group Wishes A Happy And Healthy Year 2022 From All Over The World!
04 Jan 2022 //
PRESS RELEASE
Driving Efficiency Is Key Tiefenbacher Group Enlarges Manufacturing Facilities
15 Dec 2021 //
PRESS RELEASE
Reach Out To Tiefenbacher Group At Cphi In Milan From 9-11Th Nov And Discover
06 Oct 2021 //
PRESS RELEASE
New Agreement Expands Collaboration Between Ondosis And Tiefenbacher Group
26 May 2021 //
PRESS RELEASE
New Agreement Expands Collaboration Between Ondosis And Tiefenbacher Group
19 May 2021 //
PRESS RELEASE
Spreading Of Post Covid-19 Disease "Black Fungus“ In India – Tiefenbacher Group Supports With Posaconazole Tablets
19 May 2021 //
PRESS RELEASE
Tiefenbacher Group Announces Global Launch Of Tiefenbacher Medical Devices
16 Apr 2021 //
PRESS RELEASE
Aet Pharma Us Inc. Announces Successful Approval Of Generic Posaconazole By The Food And Drug Administration (FDA)
08 Feb 2021 //
PRESS RELEASE
Tiefenbacher Pharmaceuticals Announces Global Launch Of Rivaroxaban
26 Jan 2021 //
PRESS RELEASE
International Brand Relaunch Of Tiefenbacher Group
02 Oct 2020 //
PRESS RELEASE
